Document Detail

Clearance of a 3H-labeled chylomicron-like emulsion following the acute phase of myocardial infarction.
MedLine Citation:
PMID:  14975545     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Plasma lipids may be altered during acute myocardial infarction and may not reflect patient baseline lipid profile. The metabolism of chylomicrons, the lipoproteins that carry the dietary lipids in the bloodstream has not yet been studied in acute myocardial infarction patients. METHODS: In this study, a lipidic emulsion that mimics the intravascular behavior of chylomicrons labeled with cholesteryl oleate ((3)H-CO) was injected intravenously in 17 normolipidemic patients on the seventh and on the 45th day post-non complicated acute myocardial infarction after a 12-h fast. The plasma decay curve of the emulsion label was determined from blood samples collected during 60 min. Data were also compared with a group of 10 patients with chronic coronary artery disease. RESULTS: In the acute myocardial infarction group, the plasma fractional catabolic rates of the emulsion (3)H-CO, expressed as median and confidence intervals, did not change from the seventh to the 45th day after the acute event [0.0773 (0.061, 0.1025) min(-1) vs. 0.0672 (0.00507, 0.1009) min(-1) P=0.61] and was similar to that determined in chronic coronary artery disease patients. High-density lipoprotein cholesterol and apolipoprotein AI were lower on the seventh day when compared to the 45th day post acute myocardial infarction (P=0.01 and P=0.004, respectively). No changes were found in LDL and total cholesterol as well as in plasma triglycerides in myocardial infarction group. CONCLUSIONS: No changes were found in chylomicron metabolism is in the acute phase of myocardial infarction.
Ana Paula M Chacra; Raul D Santos; Rosângela F Amâncio; Roberto Schreiber; José Antonio F Ramires; Raul C Maranhão
Related Documents :
11864795 - Coaching patients with coronary heart disease to achieve the target cholesterol: a meth...
8676835 - Why are lipids not predictive of cardiovascular death in the dialysis patient?
15789175 - Pathological changes in acute coronary syndromes: the role of statin therapy in the mod...
17627565 - Is there a true beneficial effect of statin therapy in the acute phase of unstable angi...
11758075 - Lipid lowering and coronary heart disease risk: how appropriate are the national guidel...
1671315 - Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of cardiology     Volume:  93     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-02-20     Completed Date:  2004-06-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  181-7     Citation Subset:  IM    
Heart Institute (InCor) University of São Paulo Medical School, São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholesterol Esters / diagnostic use,  pharmacokinetics
Chylomicrons / blood,  metabolism*
Middle Aged
Myocardial Infarction / metabolism*
Time Factors
Reg. No./Substance:
0/Cholesterol Esters; 0/Chylomicrons; 0/Emulsions; 10028-17-8/Tritium; 303-43-5/cholesteryl oleate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following ...
Next Document:  Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to i...